KYMR
Price
$77.64
Change
+$0.42 (+0.54%)
Updated
Feb 4, 04:59 PM (EDT)
Capitalization
6.18B
15 days until earnings call
Intraday BUY SELL Signals
REPL
Price
$7.00
Change
-$0.38 (-5.15%)
Updated
Feb 4, 04:59 PM (EDT)
Capitalization
610.21M
99 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

KYMR vs REPL

Header iconKYMR vs REPL Comparison
Open Charts KYMR vs REPLBanner chart's image
Kymera Therapeutics
Price$77.64
Change+$0.42 (+0.54%)
Volume$7.17K
Capitalization6.18B
Replimune Group
Price$7.00
Change-$0.38 (-5.15%)
Volume$93.39K
Capitalization610.21M
KYMR vs REPL Comparison Chart in %
View a ticker or compare two or three
VS
KYMR vs. REPL commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KYMR is a Buy and REPL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (KYMR: $77.22 vs. REPL: $7.38)
Brand notoriety: KYMR and REPL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KYMR: 61% vs. REPL: 74%
Market capitalization -- KYMR: $6.18B vs. REPL: $610.21M
KYMR [@Biotechnology] is valued at $6.18B. REPL’s [@Biotechnology] market capitalization is $610.21M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KYMR’s FA Score shows that 0 FA rating(s) are green whileREPL’s FA Score has 1 green FA rating(s).

  • KYMR’s FA Score: 0 green, 5 red.
  • REPL’s FA Score: 1 green, 4 red.
According to our system of comparison, REPL is a better buy in the long-term than KYMR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KYMR’s TA Score shows that 4 TA indicator(s) are bullish while REPL’s TA Score has 6 bullish TA indicator(s).

  • KYMR’s TA Score: 4 bullish, 5 bearish.
  • REPL’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, REPL is a better buy in the short-term than KYMR.

Price Growth

KYMR (@Biotechnology) experienced а +7.03% price change this week, while REPL (@Biotechnology) price change was -1.99% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.56%. For the same industry, the average monthly price growth was +1.40%, and the average quarterly price growth was +33.10%.

Reported Earning Dates

KYMR is expected to report earnings on Feb 19, 2026.

REPL is expected to report earnings on May 14, 2026.

Industries' Descriptions

@Biotechnology (-2.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYMR($6.18B) has a higher market cap than REPL($610M). KYMR YTD gains are higher at: -0.758 vs. REPL (-24.074). KYMR (-286.52M) and REPL (-298.27M) have comparable annual earnings (EBITDA) . KYMR has more cash in the bank: 506M vs. REPL (324M). REPL has less debt than KYMR: REPL (76.3M) vs KYMR (84M). KYMR has higher revenues than REPL: KYMR (43.7M) vs REPL (0).
KYMRREPLKYMR / REPL
Capitalization6.18B610M1,013%
EBITDA-286.52M-298.27M96%
Gain YTD-0.758-24.0743%
P/E RatioN/AN/A-
Revenue43.7M0-
Total Cash506M324M156%
Total Debt84M76.3M110%
FUNDAMENTALS RATINGS
REPL: Fundamental Ratings
REPL
OUTLOOK RATING
1..100
54
VALUATION
overvalued / fair valued / undervalued
1..100
26
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KYMRREPL
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
78%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 14 days ago
76%
Declines
ODDS (%)
Bearish Trend 16 days ago
86%
Bearish Trend 3 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
77%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
KYMR
Daily Signal:
Gain/Loss:
REPL
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FEFRX32.870.20
+0.61%
First Eagle Rising Dividend Fund R6
VEMAX47.240.26
+0.55%
Vanguard Emerging Mkts Stock Idx Adm
NRINX26.710.06
+0.23%
Neuberger Intrinsic Value R6
VYMVX15.13-0.02
-0.13%
Voya MI Dynamic SMID Cap R
TMLCX41.60-0.31
-0.74%
SEI Tax-Managed Large Cap F (SIMT)

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been loosely correlated with NRIX. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if KYMR jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
+2.12%
NRIX - KYMR
65%
Loosely correlated
-1.76%
CGON - KYMR
55%
Loosely correlated
-3.28%
VERA - KYMR
54%
Loosely correlated
-1.35%
IDYA - KYMR
53%
Loosely correlated
+0.50%
RGNX - KYMR
53%
Loosely correlated
+0.74%
More

REPL and

Correlation & Price change

A.I.dvisor indicates that over the last year, REPL has been loosely correlated with NEVPF. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if REPL jumps, then NEVPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To REPL
1D Price
Change %
REPL100%
+5.81%
NEVPF - REPL
64%
Loosely correlated
N/A
ELVAF - REPL
60%
Loosely correlated
N/A
IMNN - REPL
57%
Loosely correlated
N/A
SNDX - REPL
49%
Loosely correlated
-0.47%
KYMR - REPL
45%
Loosely correlated
+2.12%
More